Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Quince Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
cortexyme.comAI Executive Summary
AI-powered analysis of 8-K filing content
Three Quince Therapeutics directors (June Bray, David Lamond, Christopher Senner) tendered conditional resignations effective two business days after the October 6, 2026 Special Meeting of Stockholders, contingent on shareholder approval of three specific proposals, signaling potential governance restructuring.
Key Takeaways
Three board members have conditionally resigned, with effectiveness tied to shareholder vote outcomes on October 6, 2026
Resignations are contingent on approval of three unspecified proposals, indicating a planned governance transition rather than a crisis departure
1 more takeaway
Filing Overview
What This Means
Quince Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.